Annual Cash & Cash Equivalents
$20.01 M
-$2.98 M-12.96%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual cash & cash equivalents is $20.01 million, with the most recent change of -$2.98 million (-12.96%) on June 30, 2024.
- During the last 3 years, AYTU annual cash & cash equivalents has fallen by -$29.64 million (-59.71%).
- AYTU annual cash & cash equivalents is now -59.71% below its all-time high of $49.65 million, reached on June 30, 2021.
Performance
AYTU Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$20.11 M
+$102.00 K+0.51%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly cash and cash equivalents is $20.11 million, with the most recent change of +$102.00 thousand (+0.51%) on September 30, 2024.
- Over the past year, AYTU quarterly cash and cash equivalents has increased by +$144.00 thousand (+0.72%).
- AYTU quarterly cash and cash equivalents is now -67.71% below its all-time high of $62.26 million, reached on March 31, 2020.
Performance
AYTU Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AYTU Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.0% | +0.7% |
| 3 y3 years | -59.7% | -50.1% |
| 5 y5 years | +81.1% | -56.8% |
AYTU Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.7% | +3.3% | -43.0% | +4.8% |
| 5 y | 5-year | -59.7% | +81.1% | -67.7% | +282.3% |
| alltime | all time | -59.7% | >+9999.0% | -67.7% | -100.0% |
Aytu BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.11 M(+0.5%) |
| Jun 2024 | $20.01 M(-13.0%) | $20.01 M(+1.2%) |
| Mar 2024 | - | $19.76 M(+1.2%) |
| Dec 2023 | - | $19.53 M(-2.2%) |
| Sep 2023 | - | $19.96 M(-13.1%) |
| Jun 2023 | $22.98 M(+18.7%) | $22.98 M(+19.8%) |
| Mar 2023 | - | $19.18 M(-1.7%) |
| Dec 2022 | - | $19.50 M(-18.1%) |
| Sep 2022 | - | $23.81 M(+23.0%) |
| Jun 2022 | $19.36 M(-61.0%) | $19.36 M(-29.9%) |
| Mar 2022 | - | $27.61 M(-21.7%) |
| Dec 2021 | - | $35.28 M(-12.5%) |
| Sep 2021 | - | $40.31 M(-18.8%) |
| Jun 2021 | $49.65 M(+3.3%) | $49.65 M(+6.7%) |
| Mar 2021 | - | $46.54 M(-25.0%) |
| Dec 2020 | - | $62.03 M(+63.6%) |
| Sep 2020 | - | $37.91 M(-21.2%) |
| Jun 2020 | $48.08 M(+335.4%) | $48.08 M(-22.8%) |
| Mar 2020 | - | $62.26 M(+1083.9%) |
| Dec 2019 | - | $5.26 M(-25.0%) |
| Sep 2019 | - | $7.01 M(-36.5%) |
| Jun 2019 | $11.04 M(+57.5%) | $11.04 M(-24.6%) |
| Mar 2019 | - | $14.65 M(-17.7%) |
| Dec 2018 | - | $17.80 M(+349.1%) |
| Sep 2018 | - | $3.96 M(-43.5%) |
| Jun 2018 | $7.01 M(+774.0%) | $7.01 M(-41.6%) |
| Mar 2018 | - | $12.01 M(+207.2%) |
| Dec 2017 | - | $3.91 M(-44.3%) |
| Sep 2017 | - | $7.02 M(+775.2%) |
| Jun 2017 | $802.30 K(-90.0%) | $802.30 K(-76.9%) |
| Mar 2017 | - | $3.47 M(-33.7%) |
| Dec 2016 | - | $5.23 M(+90.3%) |
| Sep 2016 | - | $2.75 M(-65.9%) |
| Jun 2016 | $8.05 M | $8.05 M(-7.1%) |
| Mar 2016 | - | $8.67 M(-20.9%) |
| Dec 2015 | - | $10.96 M(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $10.07 M(+36.9%) |
| Jun 2015 | $7.35 M(>+9900.0%) | $7.35 M(+393.1%) |
| Mar 2015 | - | $1.49 M(>+9900.0%) |
| Feb 2015 | - | $100.00(-98.9%) |
| Nov 2014 | - | $9000.00(+291.3%) |
| Aug 2014 | $2300.00(-99.9%) | $2300.00(-74.4%) |
| Jun 2014 | $2.64 M(>+9900.0%) | - |
| May 2014 | - | $9000.00(+4400.0%) |
| Feb 2014 | - | $200.00(-50.0%) |
| Nov 2013 | - | $400.00(-78.9%) |
| Aug 2013 | $1900.00(+1800.0%) | $1900.00(+171.4%) |
| May 2013 | - | $700.00(-78.1%) |
| Feb 2013 | - | $3200.00(+357.1%) |
| Nov 2012 | - | $700.00(+600.0%) |
| Aug 2012 | $100.00(-97.5%) | $100.00(>+9900.0%) |
| May 2012 | - | $0.00(-100.0%) |
| Feb 2012 | - | $800.00(-52.9%) |
| Nov 2011 | - | $1700.00(-57.5%) |
| Aug 2011 | $4000.00(+166.7%) | $4000.00(-42.9%) |
| May 2011 | - | $7000.00(+11.1%) |
| Feb 2011 | - | $6300.00(+600.0%) |
| Nov 2010 | - | $900.00(-40.0%) |
| Aug 2010 | $1500.00(-89.0%) | $1500.00(-81.5%) |
| May 2010 | - | $8100.00(+1520.0%) |
| Feb 2010 | - | $500.00(-85.3%) |
| Nov 2009 | - | $3400.00(-75.0%) |
| Aug 2009 | $13.60 K(-63.8%) | $13.60 K(+6.3%) |
| May 2009 | - | $12.80 K(+25.5%) |
| Feb 2009 | - | $10.20 K(-43.6%) |
| Nov 2008 | - | $18.10 K(-51.9%) |
| Aug 2008 | $37.60 K(+60.7%) | $37.60 K(-13.8%) |
| May 2008 | - | $43.60 K(-24.8%) |
| Feb 2008 | - | $58.00 K(-16.1%) |
| Nov 2007 | - | $69.10 K(+195.3%) |
| Aug 2007 | $23.40 K | $23.40 K(-20.7%) |
| May 2007 | - | $29.50 K |
FAQ
- What is Aytu BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aytu BioPharma?
- What is Aytu BioPharma annual cash & cash equivalents year-on-year change?
- What is Aytu BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aytu BioPharma?
- What is Aytu BioPharma quarterly cash and cash equivalents year-on-year change?
What is Aytu BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of AYTU is $20.01 M
What is the all time high annual cash & cash equivalents for Aytu BioPharma?
Aytu BioPharma all-time high annual cash & cash equivalents is $49.65 M
What is Aytu BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, AYTU annual cash & cash equivalents has changed by -$2.98 M (-12.96%)
What is Aytu BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AYTU is $20.11 M
What is the all time high quarterly cash and cash equivalents for Aytu BioPharma?
Aytu BioPharma all-time high quarterly cash and cash equivalents is $62.26 M
What is Aytu BioPharma quarterly cash and cash equivalents year-on-year change?
Over the past year, AYTU quarterly cash and cash equivalents has changed by +$144.00 K (+0.72%)